Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Spatial and temporal epithelial ovarian cancer cell heterogeneity impacts Maraba virus oncolytic potential.

Tong JG, Valdes YR, Sivapragasam M, Barrett JW, Bell JC, Stojdl D, DiMattia GE, Shepherd TG.

BMC Cancer. 2017 Aug 30;17(1):594. doi: 10.1186/s12885-017-3600-2.

2.

A Systematic Analysis of Negative Growth Control Implicates the DREAM Complex in Cancer Cell Dormancy.

MacDonald J, Ramos-Valdes Y, Perampalam P, Litovchick L, DiMattia GE, Dick FA.

Mol Cancer Res. 2017 Apr;15(4):371-381. doi: 10.1158/1541-7786.MCR-16-0323-T. Epub 2016 Dec 28.

3.

Differences in MEK inhibitor efficacy in molecularly characterized low-grade serous ovarian cancer cell lines.

Fernández ML, DiMattia GE, Dawson A, Bamford S, Anderson S, Hennessy BT, Anglesio MS, Shepherd TG, Salamanca C, Hoenisch J, Tinker A, Huntsman DG, Carey MS.

Am J Cancer Res. 2016 Oct 1;6(10):2235-2251. eCollection 2016.

4.

TGFβ signaling regulates epithelial-mesenchymal plasticity in ovarian cancer ascites-derived spheroids.

Rafehi S, Ramos Valdes Y, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Endocr Relat Cancer. 2016 Mar;23(3):147-59. doi: 10.1530/ERC-15-0383. Epub 2015 Dec 8.

5.

Beclin-1 expression is retained in high-grade serous ovarian cancer yet is not essential for autophagy induction in vitro.

Correa RJ, Valdes YR, Shepherd TG, DiMattia GE.

J Ovarian Res. 2015 Aug 4;8:52. doi: 10.1186/s13048-015-0182-y.

6.

Intact LKB1 activity is required for survival of dormant ovarian cancer spheroids.

Peart T, Ramos Valdes Y, Correa RJ, Fazio E, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Oncotarget. 2015 Sep 8;6(26):22424-38.

7.

Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis.

Tong JG, Valdes YR, Barrett JW, Bell JC, Stojdl D, McFadden G, McCart JA, DiMattia GE, Shepherd TG.

Mol Ther Oncolytics. 2015 Sep 23;2:15013. doi: 10.1038/mto.2015.13. eCollection 2015.

8.

Combination of AKT inhibition with autophagy blockade effectively reduces ascites-derived ovarian cancer cell viability.

Correa RJ, Valdes YR, Peart TM, Fazio EN, Bertrand M, McGee J, Préfontaine M, Sugimoto A, DiMattia GE, Shepherd TG.

Carcinogenesis. 2014 Sep;35(9):1951-61. doi: 10.1093/carcin/bgu049. Epub 2014 Feb 22.

9.

Myxoma virus-mediated oncolysis of ascites-derived human ovarian cancer cells and spheroids is impacted by differential AKT activity.

Correa RJ, Komar M, Tong JG, Sivapragasam M, Rahman MM, McFadden G, Dimattia GE, Shepherd TG.

Gynecol Oncol. 2012 May;125(2):441-50. doi: 10.1016/j.ygyno.2012.01.048. Epub 2012 Feb 1.

10.

BMP signalling controls the malignant potential of ascites-derived human epithelial ovarian cancer spheroids via AKT kinase activation.

Peart TM, Correa RJ, Valdes YR, Dimattia GE, Shepherd TG.

Clin Exp Metastasis. 2012 Apr;29(4):293-313. doi: 10.1007/s10585-011-9451-3. Epub 2012 Jan 17.

PMID:
22249415
11.

Modulation of AKT activity is associated with reversible dormancy in ascites-derived epithelial ovarian cancer spheroids.

Correa RJ, Peart T, Valdes YR, DiMattia GE, Shepherd TG.

Carcinogenesis. 2012 Jan;33(1):49-58. doi: 10.1093/carcin/bgr241. Epub 2011 Oct 31.

PMID:
22045027
12.

Stanniocalcin 2 alters PERK signalling and reduces cellular injury during cerulein induced pancreatitis in mice.

Fazio EN, Dimattia GE, Chadi SA, Kernohan KD, Pin CL.

BMC Cell Biol. 2011 May 5;12:17. doi: 10.1186/1471-2121-12-17.

13.

Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.

Johnston J, Ramos-Valdes Y, Stanton LA, Ladhani S, Beier F, Dimattia GE.

Transgenic Res. 2010 Dec;19(6):1017-39. doi: 10.1007/s11248-010-9376-7. Epub 2010 Feb 20.

PMID:
20174869
14.

A functional connection between pRB and transforming growth factor beta in growth inhibition and mammary gland development.

Francis SM, Bergsied J, Isaac CE, Coschi CH, Martens AL, Hojilla CV, Chakrabarti S, Dimattia GE, Khoka R, Wang JY, Dick FA.

Mol Cell Biol. 2009 Aug;29(16):4455-66. doi: 10.1128/MCB.00473-09. Epub 2009 Jun 8.

15.

Stanniocalcin 2 expression is regulated by hormone signalling and negatively affects breast cancer cell viability in vitro.

Raulic S, Ramos-Valdes Y, DiMattia GE.

J Endocrinol. 2008 Jun;197(3):517-29. doi: 10.1677/JOE-08-0043.

16.

The stanniocalcin family of proteins.

Wagner GF, Dimattia GE.

J Exp Zool A Comp Exp Biol. 2006 Sep 1;305(9):769-80. Review.

PMID:
16902962
17.

Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs.

Gagliardi AD, Kuo EY, Raulic S, Wagner GF, DiMattia GE.

Am J Physiol Endocrinol Metab. 2005 Jan;288(1):E92-105. Epub 2004 Sep 14.

18.

Regulation of luteal cell big stanniocalcin production and secretion.

Paciga M, DiMattia GE, Wagner GF.

Endocrinology. 2004 Sep;145(9):4204-12. Epub 2004 Jun 10.

PMID:
15192041
19.

IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms.

Pozzi G, Guidi M, Laudicina F, Marazzi M, Falcone L, Betti R, Crosti C, Müller EE, DiMattia GE, Locatelli V, Torsello A.

J Endocrinol Invest. 2004 Feb;27(2):142-9.

PMID:
15129809
20.

Targeting of big stanniocalcin and its receptor to lipid storage droplets of ovarian steroidogenic cells.

Paciga M, McCudden CR, Londos C, DiMattia GE, Wagner GF.

J Biol Chem. 2003 Dec 5;278(49):49549-54. Epub 2003 Sep 25.

21.
22.

Effects of dibutyryl cAMP on stanniocalcin and stanniocalcin-related protein mRNA expression in neuroblastoma cells.

Wong CK, Yeung HY, Mak NK, DiMattia GE, Chan DK, Wagner GF.

J Endocrinol. 2002 Apr;173(1):199-209.

23.

Overexpression of human stanniocalcin affects growth and reproduction in transgenic mice.

Varghese R, Gagliardi AD, Bialek PE, Yee SP, Wagner GF, Dimattia GE.

Endocrinology. 2002 Mar;143(3):868-76.

PMID:
11861508
24.
25.

Novel expression of the stanniocalcin gene in fish.

McCudden CR, Kogon MR, DiMattia GE, Wagner GF.

J Endocrinol. 2001 Oct;171(1):33-44.

26.

Dynamic changes in stanniocalcin gene expression in the mouse uterus during early implantation.

Stasko SE, DiMattia GE, Wagner GF.

Mol Cell Endocrinol. 2001 Mar 28;174(1-2):145-9.

PMID:
11306181
27.

Dynamic regulation of mouse ovarian stanniocalcin expression during gestation and lactation.

Deol HK, Varghese R, Wagner GF, Dimattia GE.

Endocrinology. 2000 Sep;141(9):3412-21.

PMID:
10965914
28.

GERp95, a membrane-associated protein that belongs to a family of proteins involved in stem cell differentiation.

Cikaluk DE, Tahbaz N, Hendricks LC, DiMattia GE, Hansen D, Pilgrim D, Hobman TC.

Mol Biol Cell. 1999 Oct;10(10):3357-72.

29.

DNase I hypersensitivity analysis of non-pituitary human prolactin gene expression.

Gaasenbeek M, Gellersen B, DiMattia GE.

Mol Cell Endocrinol. 1999 Jun 25;152(1-2):147-59.

PMID:
10432232
30.

Molecular cloning and characterization of stanniocalcin-related protein.

DiMattia GE, Varghese R, Wagner GF.

Mol Cell Endocrinol. 1998 Nov 25;146(1-2):137-40.

PMID:
10022771
31.

Comparative analysis of mammalian stanniocalcin genes.

Varghese R, Wong CK, Deol H, Wagner GF, DiMattia GE.

Endocrinology. 1998 Nov;139(11):4714-25.

PMID:
9794484
32.

The Pit-1 gene is regulated by distinct early and late pituitary-specific enhancers.

DiMattia GE, Rhodes SJ, Krones A, Carrière C, O'Connell S, Kalla K, Arias C, Sawchenko P, Rosenfeld MG.

Dev Biol. 1997 Feb 1;182(1):180-90.

33.

Pituitary-type transcription of the human prolactin gene in the absence of Pit-1.

Gellersen B, Kempf R, Telgmann R, DiMattia GE.

Mol Endocrinol. 1995 Jul;9(7):887-901.

PMID:
7476971
34.

Apolipoprotein (apo) B and apoII gene expression are both estrogen-responsive in chick embryo liver but only apoII is estrogen-responsive in kidney.

Lazier CB, Wiktorowicz M, DiMattia GE, Gordon DA, Binder R, Williams DL.

Mol Cell Endocrinol. 1994 Dec;106(1-2):187-94.

PMID:
7895907
35.

Transcriptional mechanisms in anterior pituitary cell differentiation.

Rhodes SJ, DiMattia GE, Rosenfeld MG.

Curr Opin Genet Dev. 1994 Oct;4(5):709-17. Review.

PMID:
7849511
36.
37.

A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene.

Rhodes SJ, Chen R, DiMattia GE, Scully KM, Kalla KA, Lin SC, Yu VC, Rosenfeld MG.

Genes Dev. 1993 Jun;7(6):913-32.

38.

Expression of the albumin gene in the yolk sac and liver during chick embryogenesis.

Dimattia GE, Lazier CB.

Comp Biochem Physiol B. 1993 Apr;104(4):825-32.

PMID:
8472547
39.

Molecular cloning and cDNA sequence analysis of coho salmon stanniocalcin.

Wagner GF, Dimattia GE, Davie JR, Copp DH, Friesen HG.

Mol Cell Endocrinol. 1992 Dec;90(1):7-15.

PMID:
1363790
40.

Posttranscriptional regulation of the human prolactin gene in IM-9-P3 cells by retinoic acid.

Gellersen B, Kempf R, Hartung S, Bonhoff A, DiMattia GE.

Endocrinology. 1992 Sep;131(3):1017-25.

PMID:
1324146
41.

Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia.

Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham HA.

Science. 1992 Aug 21;257(5073):1118-21.

PMID:
1509263
42.

A BglII RFLP at the human prolactin gene locus on chromosome 6 (PRL).

Myal Y, DiMattia GE, Gregory CA, Friesen HG, Hamerton JL, Shiu RP.

Nucleic Acids Res. 1991 Mar 11;19(5):1167. No abstract available.

43.

Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line.

DiMattia GE, Gellersen B, Duckworth ML, Friesen HG.

J Biol Chem. 1990 Sep 25;265(27):16412-21.

44.
45.

Phorbol ester stimulates prolactin release but reduces prolactin mRNA in the human B-lymphoblastoid cell line IM-9-P3.

Gellersen B, DiMattia GE, Friesen HG, Bohnet HG.

Mol Cell Endocrinol. 1989 Oct;66(2):153-61.

PMID:
2482208
46.

Prolactin (PRL) mRNA from human decidua differs from pituitary PRL mRNA but resembles the IM-9-P3 lymphoblast PRL transcript.

Gellersen B, DiMattia GE, Friesen HG, Bohnet HG.

Mol Cell Endocrinol. 1989 Jun;64(1):127-30.

PMID:
2759338
47.

Role of calcium in prolactin-stimulated c-myc gene expression and mitogenesis in Nb2 lymphoma cells.

Murphy PR, DiMattia GE, Friesen HG.

Endocrinology. 1988 Jun;122(6):2476-85.

PMID:
3131117
48.

A human B-lymphoblastoid cell line produces prolactin.

DiMattia GE, Gellersen B, Bohnet HG, Friesen HG.

Endocrinology. 1988 Jun;122(6):2508-17.

PMID:
2836165

Supplemental Content

Loading ...
Support Center